Bristol-Myers Squibb Co BMY

Healthcare

Bristol-Myers Squibb Company is a biopharmaceutical company engaged in the discovery, development and delivering advanced medicines that help patients prevail over serious diseases. It offers products for various therapeutic classes, which includes oncology, hematology, immunology, cardiovascular and neuroscience. Its pharmaceutical products include chemically synthesized or small molecule drugs, products produced from biological processes, called biologics and chimeric antigen receptor (CAR-T) cell therapies. Small molecule drugs are typically administered orally in the form of a tablet or capsule, although other drug delivery mechanisms are used as well. Biologics are administered to patients through injections or by intravenous infusion. Its in-line products include Eliquis, Opdivo, Orencia, Pomalyst/Imnovid, Yervoy, Sprycel, Reblozyl, Opdualag, Abecma, Zeposia, and others. The Company's product pipeline includes Krazati, MRTX1719, RYZ101, KarXT, ORM-6151, and Repotrectinib.

NYSE:BMY - Post by User

Bristol-Myers Squibb Co > 🥇💊$HUGE FSD PHARMA COVID19 FDA PHASE 2A🥇💊

<< Previous

Bullboard Posts

Next >>

Comment by techfan49on Jan 03, 2021 12:22am

161 Views

Post# 32210793

RE:🥇💊$HUGE FSD PHARMA COVID19 FDA PHASE 2A🥇💊

FSD is a poorly run public company that has spent a lot of money trying to bring in more.shareholder money and.in the end did not satisfy the market's expectations. Do not touch FSD aka HUGE . As an investor there are many companies like BMY That don't hire 3rd party pumpsters who visit messageboards and are fishing for more cash.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario